University of Cambridge is offering a fully funded PhD studentship in the Department of Pathology, starting October 2027, to investigate functional effects of dysregulated microRNA pathways in malignant germ cell tumours. Applicants should have UK upper 2.1 or higher and meet Home Fees requirements; language criteria must be fulfilled by interview time.
The project will involve in vitro studies, combination approaches with cisplatin, and collaboration with group leaders across a dynamic research
#J-18808-Ljbffr
Fully Funded PhD: miRNA Pathways in Germ Cell Tumours in Cambridge employer: University of Cambridge
The University of Cambridge offers a dynamic and collaborative work environment, particularly within the Department of Oncology, where you will play a pivotal role in advancing cancer research. With a strong emphasis on employee growth, you will have access to professional development opportunities and the chance to work alongside leading experts in the field. The university's commitment to innovation and excellence ensures that your contributions will have a meaningful impact on clinical care and research outcomes.
